Related references
Note: Only part of the references are listed.36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Alexander G. G. Turpie et al.
THROMBOSIS RESEARCH (2023)
Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis
Sally Bevan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
Thure Filskov Overvad et al.
BLOOD ADVANCES (2022)
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Dominique Farge et al.
LANCET ONCOLOGY (2022)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?
Anna Falanga et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis
Nick van Es et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update
Anjlee Mahajan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis
Wenhan Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Khorana Score: ew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
Ioannis Vathiotis et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Cihan Ay et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer A population-based cohort study
Alexander T. Cohen et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Mechanisms and risk factors of thrombosis in cancer
Anna Falange et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients
T. van der Hulle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The epidemiology of venous thromboembolism
John A. Heit et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality
Nicole M. Kuderer et al.
ONCOLOGIST (2016)
Epidemiology of venous thromboembolism in the Framingham Heart Study
Marja K. Puurunen et al.
THROMBOSIS RESEARCH (2016)
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH
M. Di Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Impact of preoperative anemia on relapse and survival in breast cancer patients
YingJun Zhang et al.
BMC CANCER (2014)
Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?
U. Pelzer et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2013)
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Alok A. Khorana et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2013)
Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Yngve Falck-Ytter et al.
CHEST (2012)
Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
Patrizia Ferroni et al.
CLINICAL LUNG CANCER (2012)
High D-dimer levels are associated with poor prognosis in cancer patients
Cihan Ay et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Incidental venous thromboembolism in oncology patients
A. A. KHORANA et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Risk of Recurrent Venous Thromboembolism and Mortality in Patients With Cancer Incidentally Diagnosed With Pulmonary Embolism: A Comparison With Symptomatic Patients
Paul L. den Exter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
Gregory C. Connolly et al.
THROMBOSIS RESEARCH (2010)
Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors
Ted Wun et al.
CANCER INVESTIGATION (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy - An underestimated phenomenon
HMMB Otten et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Share Paper
